2018

1. Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial

   Radiotherapy and Oncology, Vol. 126, Núm. 2, pp. 278-282

2. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer

   International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178